Topic: ADAP
Stock Highlights: Adaptimmune Therapeutics (NASDAQ: ADAP)
Adaptimmune Therapeutics trades as part of the healthcare sector and is part of the biotechnology industry. The company CEO is James J. Noble. Adaptimmune Therapeutics along with its subsidiaries is a clinical-stage biopharmaceutical...










